Experimental Drug Development Centre
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Singapore · 11-50 Employees
View Company Info for Free
Overview
Headquarters
10 Biopolis Chromos Rd 05-01, Singapore,...Website
www.eddc.sgRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Experimental Drug Development Centre
The Experimental Drug Development Centre (EDDC) is Singapore's national platform for drug discovery and development, collaborating with public sector and industry partners to translate scientific discoveries into biotherapeutic candidates. EDDC focuses on developing innovative therapeutics and companion diagnostics to improve patient outcomes, particularly for those with unmet medical needs. Their notable project, ETC-159, is a small molecule Wnt-porcupine inhibitor that has shown promise in clinical trials for patients with platinum-resistant ovarian cancer. EDDC welcomes partnerships to accelerate the development of their pipeline assets and enhance drug discovery efforts.Explore more
Experimental Drug Development Centre Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Experimental Drug Development Centre your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Click to see if Experimental Drug Development Centre had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Experimental Drug Development Centre
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Experimental Drug Development Centre launches new products
Earning: See what the market has to say on Experimental Drug Development Centre recently announced quarterly report
Funding: Get notified immidiatlly once Experimental Drug Development Centre has new funding data
Experimental Drug Development Centre, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Experimental Drug Development Centre has recently received funding, and reach out quickly before it becomes old news!
Check out if Experimental Drug Development Centre is spiking on competitors!
Recommended Actions
Find VP level buyers at Experimental Drug Development Centre
Find 3 more new buyers
Company Profile Activity
Activity Insights
Experimental Drug Development Centre is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Experimental Drug Development Centre is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Experimental Drug Development Centre.
Experimental Drug Development Centre Tech Stack
A closer look at the technologies used by Experimental Drug Development Centre
See more technologies
Experimental Drug Development Centre News & Media
Experimental Drug Development Centre Granted U.S. FDA Fast Track Designation for Antibody-Drug Conjugate EBC-129 to Treat Pancreatic Ductal Adenocarcinoma
EBC-129 is the first made-in-Singapore antibody-drug conjugate (ADC) to enter clinical development. It selectively targets a tumour-specific N-glycosylated epitope on both CEACAM5 and CEACAM6. The Fast Track Designation highlights the potential of EBC-129 to address critical unmet needs in pancreatic ductal adenocarcinoma (PDAC). Updated clinical data from the ongoing Phase 1 study of EBC-129 will be presented at the 2025 Annual Meeting of the American Society of Clinical Oncology (ASCO). SINGAPEngine Biosciences and Experimental Drug Development Centre Partner to Advance Novel Therapies to Combat Cancer
This marks the first-ever collaboration between Engine Biosciences and Experimental Drug Development Centre (EDDC), Singapore's national platform for drug discovery and development. The partnership will advance the development of first-in-class precision therapeutics for multiple cancer types that are highly prevalent in Singapore and globally, including breast, liver, kidney and prostate cancers. SINGAPORE, April 8, 2025 /PRNewswire/ -- Engine Biosciences (Engine), a Singapore- and Silicon Vall
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Experimental Drug Development Centre
Sign Up For FreeTo access detailed company insights
The Experimental Drug Development Centre (EDDC) is Singapore's national platform for drug discovery and development, collaborating with public sector and industry partners to translate scientific discoveries into biotherapeutic candidates. EDDC focuses on developing innovative therapeutics and companion diagnostics to improve patient outcomes, part... Read More
